Please use this identifier to cite or link to this item: http://hdl.handle.net/10397/33852
Title: East meets west in the search for alzheimer's therapeutics - novel dimeric inhibitors from tacrine and huperzine A
Authors: Li, WM
Kan, KKW
Carlier, PR
Pang, YP
Han, YF 
Keywords: Alzheimer's disease
Acetylcholinesterase inhibitor
Bis(7)-tacrine
Dimers
Neuroprotection
Issue Date: 2007
Publisher: Bentham Science Publishers
Source: Current alzheimer research, 2007, v. 4, no. 4, p. 386-396 How to cite?
Journal: Current alzheimer research 
Abstract: Alzheimer's disease (AD) is linked to cholinergic deficiency and the overactivation of glutamate receptors. The acetylcholinesterase (AChE) inhibition treatment approach has produced the most encouraging results in clinical practice, and memantine, a moderate antagonist of N-methyl-D-aspartate (NMDA) receptors, has been approved for treating AD. However, AChE inhibitors have limited success as they only improve memory in mild dementia but cannot stop the process of neurodegeneration; while memantine possesses neuroprotective effects only with a little ability in memory enhancement. There has been a major rush among neuroscience research institutions and pharmaceutical firms worldwide to search for safer and more effective therapeutic agents for AD. The novel dimers, derived from tacrine and the fragment of huperzine A (HA'), have been demonstrated to be potent and selective reversible inhibitors of AChE. Bis(7)-tacrine, bis(12)-hupyridone (E12E) and HA'(10)-tacrine, are representatives of three series of novel dimers. According to the preclinical studies, these compounds have been shown to have low toxicity and high efficacy for improving cognitive deficits in several animal models. More interestingly, bis(7)-tacrine, similar to memantine, prevents glutamate-induced neurotoxicity by moderately blocking glutamate receptor NMDA subtype. Furthermore, bis(7)-tacrine, as well as E12E, possesses multiple neuroprotective effects in vitro and in vivo. Taking together, these dimeric AChE inhibitors, especially bis(7)- tacrine, E12E and HA'(10)-tacrine, may provide beneficial effects in AD and other neurodegenerative diseases.
URI: http://hdl.handle.net/10397/33852
DOI: 10.2174/156720507781788918
Appears in Collections:Journal/Magazine Article

Access
View full-text via PolyU eLinks SFX Query
Show full item record

SCOPUSTM   
Citations

37
Last Week
2
Last month
Citations as of Sep 16, 2017

WEB OF SCIENCETM
Citations

37
Last Week
0
Last month
0
Citations as of Sep 23, 2017

Page view(s)

44
Last Week
1
Last month
Checked on Sep 24, 2017

Google ScholarTM

Check

Altmetric



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.